Normal Saline Group for Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
CancerNormal Saline Group - Drug
Eligibility
18 - 80
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether using Normal Saline Flushes instead of Heparin Flushes to keep central lines open is just as effective in preventing line occlusion.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: From Day 1 and up to Day 7 of enrollment

Day 7
Infection Rate
Day 7
Patency

Trial Safety

Trial Design

2 Treatment Groups

Heparin Group
1 of 2
Normal Saline Group
1 of 2

Active Control

Experimental Treatment

175 Total Participants · 2 Treatment Groups

Primary Treatment: Normal Saline Group · No Placebo Group · Phase < 1

Normal Saline Group
Drug
Experimental Group · 1 Intervention: Normal Saline Group · Intervention Types: Drug
Heparin Group
Drug
ActiveComparator Group · 1 Intervention: Heparin Group · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from day 1 and up to day 7 of enrollment

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
953 Previous Clinical Trials
608,571 Total Patients Enrolled
Kavitha NairStudy ChairUniversity of Texas Southwestern Medical Center
Meredith C Allen, BSNPrincipal InvestigatorUniversity of Texas Southwestern Medical Center
Teresa PhanStudy ChairUniversity of Texas Southwestern Medical Center
Ramona WarkolaStudy ChairUniversity of Texas Southwestern Medical Center
Jancy WilsonStudy ChairUniversity of Texas Southwestern Medical Center
Linda DenkeStudy DirectorUniversity of Texas Southwestern Medical Center
Miriam GonzalesStudy ChairUniversity of Texas Southwestern Medical Center

Eligibility Criteria

Age 18 - 80 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you: